odiparcil has been researched along with glycosides in 5 studies
| Studies (odiparcil) | Trials (odiparcil) | Recent Studies (post-2010) (odiparcil) | Studies (glycosides) | Trials (glycosides) | Recent Studies (post-2010) (glycosides) |
|---|---|---|---|---|---|
| 13 | 2 | 10 | 20,179 | 169 | 6,844 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (60.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abboud, MA; Burns-Kurtis, CL; Danoff, TM; Erhardt, JA; Koster, PF; Pillarisetti, K; Toomey, JR; Valocik, RE | 1 |
| Eddington, ND; Khurana, M; Myers, AL; Upreti, VV | 1 |
| Bocart, S; Bouchot, A; Bournique, B; Broqua, P; Entchev, E; Jantzen, I; Junien, JL; Lacombe, O; Luccarini, JM; Masson, P; Tallandier, M | 1 |
| Antonelli, S; Cimbolini, N; Entchev, E; Feraille, L; Germain, JM; Jantzen, I; Lacombe, O; Luccarrini, JM; Mauro, V; Roussey, A; Tallandier, M; Young, SP; Zhang, H | 1 |
| Abitbol, JL; Chowdary, P; Faudot-Vernier, E; Fiquet, A; Guffon, N; Hendriksz, CJ; Hennermann, JB; Hughes, D; Huot-Marchand, P; Lacombe, O; Richard, MP; Tallandier, M; Teles, EL | 1 |
2 trial(s) available for odiparcil and glycosides
| Article | Year |
|---|---|
Characterization of total plasma glycosaminoglycan levels in healthy volunteers following oral administration of a novel antithrombotic odiparcil with aspirin or enoxaparin.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aspirin; Chromatography, High Pressure Liquid; Drug Interactions; Enoxaparin; Female; Fibrinolytic Agents; Glycosaminoglycans; Glycosides; Humans; Liver Function Tests; Male; Middle Aged; Young Adult | 2008 |
Oral treatment for mucopolysaccharidosis VI: Outcomes of the first phase IIa study with odiparcil.
Topics: Enzyme Replacement Therapy; Glycosaminoglycans; Glycosides; Humans; Mucopolysaccharidoses; Mucopolysaccharidosis VI; N-Acetylgalactosamine-4-Sulfatase | 2022 |
3 other study(ies) available for odiparcil and glycosides
| Article | Year |
|---|---|
A comparison of the beta-D-xyloside, odiparcil, to warfarin in a rat model of venous thrombosis.
Topics: Animals; Anticoagulants; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Glycosaminoglycans; Glycosides; Hemorrhage; Heparin Cofactor II; Protamines; Rats; Vena Cava, Inferior; Venous Thrombosis; Warfarin | 2006 |
Odiparcil, a potential glycosaminoglycans clearance therapy in mucopolysaccharidosis VI-Evidence from in vitro and in vivo models.
Topics: Administration, Oral; Animals; Cattle; Cells, Cultured; Chondroitin Sulfates; Dermatan Sulfate; Disease Models, Animal; Endothelial Cells; Female; Glycosaminoglycans; Glycosides; Humans; In Vitro Techniques; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Mucopolysaccharidosis VI; Rats; Rats, Sprague-Dawley | 2020 |
MPS VI associated ocular phenotypes in an MPS VI murine model and the therapeutic effects of odiparcil treatment.
Topics: Animals; Disease Models, Animal; Eye; Eye Diseases; Glycosides; Humans; Mice; Mucopolysaccharidosis VI; N-Acetylgalactosamine-4-Sulfatase; Phenotype | 2022 |